Table 3. Post-treatment outcomes and follow-up.

Patient SL. No.a	Post-procedure additional morbidityb	CDG	PPSS	PPSS risk category (Intermediate; 2-5 vs. high; >5)	ICU (Yes/No)	LoHS (Days) (Days)	Mortality (90-day, in-hospital)	Follow-up (Days)	Recurrence (Yes/No)
1	Tracheostomy	3a	4	Intermediate	Yes	31	No, No	5929	No
2	CLABSI, VAP, multi-organ failure	4b	10	High	Yes	68	No, No	1507	No
3	None	N/A	3	Intermediate	Yes	18	No, No	272	No
4	None	N/A	9	High	No	17	No, No	49	No
5	None	N/A	9	High	Yes	20	No, No	3467	No
6	VAP, tracheostomy	3b	10	High	Yes	38	No, No	17	No
7	None	N/A	6	High	Yes	19	No, No	65	No
8	Bleeding from a hiatal vessel needing laparoscopic ligation	3b	11	High	Yes	40	No, No	3007	No
9	PSVT treated medically	3a	12	High	Yes	12	No, No	2956	No
10	None	N/A	6	High	No	32	No, No	2630	No
11	VAP, tracheostomy	5	12	High	Yes	101	No, Yes	N/A	N/A
12	None	N/A	8	High	Yes	17	No, No	1142	No
CDG: Clavien-Dindo grading, ICU: Intensive care unit, LoHS: Length of hospital stay, CLABSI: Central-line associated bloodstream infection, VAP: Ventilator-associated pneumonia, PSVT: Paroxysmal supraventricular tachycardia, N/A: Not applicable. a: Patient serial number in the same order as in Table 2. b: Additional post-procedure morbidity (excluding any form of esophago-pleural re-interventions).